Interrogation of Rab8 as a therapeutic target for Huntington's disease in Drosophila melanogaster
Huntington’s disease (HD) is a familial neurodegenerative disorder largely caused by atrophy in the striatal and cortical regions of the brain. At the molecular level HD is triggered by a trinucleotide CAG repeat expansion in the Huntingtin gene (HTT), which encodes a poly glutamine (polyQ) stretch,...
Main Author: | Delfino, Laura |
---|---|
Other Authors: | Rosato, Ezio ; Giorgini, Flaviano |
Published: |
University of Leicester
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.718724 |
Similar Items
-
Validation of HDAC6 and SIRT2 tubulin deacetylases as therapeutic targets for Huntington's disease
by: Bobrowska, Anna
Published: (2012) -
Psychological distress in the context of Huntington's disease
by: Theed, Rachael
Published: (2016) -
The ubiquitin proteasome system in Huntington's disease
by: Jolly, R. S.
Published: (2008) -
MRI and cognitive changes in Huntington's disease
by: Henley, Susie M. D.
Published: (2008) -
Attentional dysfunction as a prodrome for Huntington's disease
by: Margison, Stephen
Published: (2000)